Literature DB >> 15012604

Regulation of estrogen receptor-alpha expression by the tumor suppressor gene p53 in MCF-7 cells.

S V Angeloni1, M B Martin, P Garcia-Morales, M D Castro-Galache, J A Ferragut, M Saceda.   

Abstract

The results presented here demonstrate that p53 upregulates estrogen receptor-alpha (ER alpha) expression in the human breast cancer cell line MCF-7. Two approaches were used to alter the activity of p53 in the cells. In the first approach, stable transfectants expressing an antisense p53 were established. In the stable clones, expression of antisense p53 resulted in a decrease in the expression of ER alpha protein. In the second approach, MCF-7 cells were transiently transfected with wild-type p53. Overexpression of p53 increased the amount of ER alpha. To determine whether the effects of p53 on the expression of ER alpha were due to changes in transcription, deletion mutants of the ER alpha promoter were used. This experimental approach demonstrated that p53 up-regulates ER alpha gene expression by increasing transcription of the gene through elements located upstream of promoter A. Transfection assays using p53 mutants further demonstrated that the p53-induced increase in ER alpha gene transcription was not dependent on the ability of p53 to bind to DNA but on its ability to interact with other proteins.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15012604     DOI: 10.1677/joe.0.1800497

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  37 in total

Review 1.  Intrinsic and Extrinsic Factors Governing the Transcriptional Regulation of ESR1.

Authors:  David K Lung; Rebecca M Reese; Elaine T Alarid
Journal:  Horm Cancer       Date:  2020-06-26       Impact factor: 3.869

Review 2.  Tumor suppressor p53 and estrogen receptors in nuclear-mitochondrial communication.

Authors:  Nadi T Wickramasekera; Gokul M Das
Journal:  Mitochondrion       Date:  2013-10-29       Impact factor: 4.160

Review 3.  Role of epigenetic modifications in luminal breast cancer.

Authors:  Hany A Abdel-Hafiz; Kathryn B Horwitz
Journal:  Epigenomics       Date:  2015-02-17       Impact factor: 4.778

4.  p53 Binds to estrogen receptor 1 promoter in human breast cancer cells.

Authors:  Mozhgan Rasti; Rita Arabsolghar; Zahed Khatooni; Zoherh Mostafavi-Pour
Journal:  Pathol Oncol Res       Date:  2011-06-08       Impact factor: 3.201

5.  P53 genotype as a determinant of ER expression and tamoxifen response in the MMTV-Wnt-1 model of mammary carcinogenesis.

Authors:  Robin Fuchs-Young; Stephanie H Shirley; Isabel Lambertz; Jennifer K L Colby; Jie Tian; Dennis Johnston; Irma B Gimenez-Conti; Lawrence A Donehower; Claudio J Conti; Stephen D Hursting
Journal:  Breast Cancer Res Treat       Date:  2010-12-30       Impact factor: 4.872

6.  Orphan receptor NR4A3 is a novel target of p53 that contributes to apoptosis.

Authors:  Olga Fedorova; Alexey Petukhov; Alexandra Daks; Oleg Shuvalov; Tatyana Leonova; Elena Vasileva; Nikolai Aksenov; Gerry Melino; Nikolai A Barlev
Journal:  Oncogene       Date:  2018-11-19       Impact factor: 9.867

7.  Tumor suppressor protein p53 negatively regulates human pregnane X receptor activity.

Authors:  Ayesha Elias; Jing Wu; Taosheng Chen
Journal:  Mol Pharmacol       Date:  2013-03-27       Impact factor: 4.436

8.  Mutant p53 binds to estrogen receptor negative promoter via DNMT1 and HDAC1 in MDA-MB-468 breast cancer cells.

Authors:  Rita Arabsolghar; Tayebeh Azimi; Mozhgan Rasti
Journal:  Mol Biol Rep       Date:  2012-12-15       Impact factor: 2.316

9.  Transcriptional regulation of estrogen receptor-alpha by p53 in human breast cancer cells.

Authors:  Stephanie Harkey Shirley; Joyce E Rundhaug; Jie Tian; Noirin Cullinan-Ammann; Isabel Lambertz; Claudio J Conti; Robin Fuchs-Young
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

Review 10.  The p53-estrogen receptor loop in cancer.

Authors:  C Berger; Y Qian; X Chen
Journal:  Curr Mol Med       Date:  2013-09       Impact factor: 2.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.